Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole in Huntington's Disease
NCT00277602Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 1999
- Primary completion
- Jul 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of riluzole in Huntington disease (HD), sponsored by Sanofi. Started Nov 1999; status: completed.
02
Drugs
riluzole
03
Conditions
Huntington disease (HD)
Beyond the preview
Go deeper on NCT00277602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00277602.